AI Trust Score, Reviews & Company Verification
Is this your company? Claim the Bayer profile to verify ownership and manage company-provided details.
Independent company assessment
8.5/10B · Solid
37 indexed evidence signals reviewed
AI Comparison
Warning Signals84% Confidence
Based on 5 polled AI models
- GeminiGoogle DeepMindWarning85%Confidence
- GrokxAIWarning82%Confidence
- DeepSeekDeepSeekWarning85%Confidence
- GLMZ.aiWarning78%Confidence
Key stats
- Sector
- Pharmaceutical Companies
- Headquarters
- US
- Domain
- bayer.com
- Domain history
- Not available
- Risk tier
- Moderate
- Assessed
- Aug 27, 2026
Bayer hasn't claimed this profile yet
ShouldEye AI builds this page from public sources. Nothing here is approved by Bayer.
- Reply to reviews
- Publish your brand message
- Earn the trust seal
Claiming gives you a voice, not control of the trust score.
Free for verified company teams
Bayer is a German multinational pharmaceutical and biotechnology company with core competencies in the life science fields of health care and agriculture.
- Headquarters
- US
Full intelligence report for Bayer
Bayer demonstrates strong operational maturity in privacy and customer service, supported by solid advertising and domain integrity practices that reflect stable, consumer-facing infrastructure. These strengths are contrasted by comparatively modest legal compliance and mixed signals across regulatory alignment, reputation, and consumer reviews, suggesting ongoing friction with complex oversight and public sentiment. The overall profile points to a generally trustworthy organization with robust safeguards in direct consumer interactions, though legal and perceptual gaps remain visible.
- Recognized with multiple industry awards for innovation, learning programs, and procurement transformation
- Identified as a top employer in Canada and the Greater Toronto Area
- Publicly acknowledges the need to rebuild trust and integrates sustainability into operations
- Historical sale of HIV‑infected blood products resulting in infections and deaths
- Ongoing multi‑billion‑dollar litigation and settlements related to glyphosate’s alleged carcinogenicity
- Reputational damage from the Monsanto acquisition and investigations into secret‑file compiling on journalists and politicians
Connect with Bayer
Find us across the web
- TikTok
- YouTube
- X
- Threads
- Snapchat
- Discord
No social profiles found yet.
Public-facing leadership and ownership signals for Bayer — synthesized from verified profiles and corporate disclosures where available.